BioSpace News Archive

Advanced critical SUI feasibility study for late summer readout Achieved FDA clearance to conduct pivotal SUI PURSUIT Trial Company to host conference call at 5:00 PM ET today

Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, announced that it participated in Canaccord Genuity’s 40 th Annual Growth Conference in a Fireside C

Inc. magazine today revealed that BioPoint Inc. is No. 2867 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. T

DeltaTrak®, a leading innovator of cold chain solutions, is enhancing its Cold Chain Restart Program to offer customers safer and more efficient methods to protect their employees and clients from the COVID-19 pandemic.

Osprey Medical, Inc. (ASX:OSP) (Osprey or the Company) is pleased to announce that the Company has received CE Marking for the DyeVert Power XT 2nd generation device.

Hudson Regional Hospital has closed on its $76M purchase of the Bayonne Medical Center property and resubmitted a competitive binding offer with proof of funds to purchase the hospital operations from its current operator, CarePoint.

The Georgia Dental Association in conjunction with the American Dental Association respectfully yet strongly disagrees with the World Health Organization’s recommendation to delay “routine” dental care in certain situations due to COVID-19.

Aquavit Pharmaceuticals, Inc. (“Aquavit”) secured Compensatory sanctions against counterfeiters in the United States District Court for the Southern District of New York in a civil action against U-Bio Med, Inc., et al.

Through educational collaboration, the organizations offer advanced training to healthcare providers via a web-based learning platform

While many concerned Gulf Coast residents wait for days to receive results from COVID-19 testing, a newly-expanded local lab is processing up to 4,000 rapid tests per day with results in 24-48 hours.